Establishing blood levels in normal individuals of markers that are dysregulated in cancerous tumours
Not Applicable
- Registration Number
- CTRI/2022/04/041837
- Lead Sponsor
- Exsegen Genomics Research Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Male or female age of = 18 years and less than 80 at the time of signing informed consent form.
-Provision of signed and dated informed consent form.
-Fit and healthy individual.
Exclusion Criteria
-Patient in any active disease state
Pregnancy
-Patients suspected or diagnosed with any type of malignancy
-Prolonged cortico-steroid therapy or immunosuppressive therapy
-Active or latent hepatitis B or active hepatitis C or any uncontrolled infection at screening
Human Immunodeficiency Virus (HIV) positive
Active infections, COVID 19, HPV, HBV, HCV, Tuberculosis etc.
-Patient has an investigational medicinal product within the last 30 days of blood collection.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective of this study is to examine the baseline exosomal profiles in healthy individuals.Timepoint: At baseline
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil